Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-09-19

Clinical Trial Update: Lithium Versus Paroxetine in Major Depression [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing lithium versus paroxetine for major depressive disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lithium (Lithium carbonate)
  • Paroxetine (Paroxetine hydrochloride)

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Major Depressive Disorder | Phase 4 | Status: WITHDRAWN